Article metrics

Download PDFPDF

Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial

Statistics from

Online download statistics by month:

Online download statistics by month: April 2019 to September 2019

Apr 201913413633
May 201916531683649
Jun 201911171087321
Jul 2019540509241
Aug 2019343303138
Sep 2019252200103